| Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant X Deng, MA Garcia-Knight, MM Khalid, V Servellita, C Wang, MK Morris, ... Cell 184 (13), 3426-3437. e8, 2021 | 699* | 2021 |
| Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms DE Gordon, J Hiatt, M Bouhaddou, VV Rezelj, S Ulferts, H Braberg, ... Science 370 (6521), eabe9403, 2020 | 626 | 2020 |
| An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike M Schoof, B Faust, RA Saunders, S Sangwan, V Rezelj, N Hoppe, ... Science 370 (6523), 1473-1479, 2020 | 429* | 2020 |
| Genetic screens identify host factors for SARS-CoV-2 and common cold coronaviruses R Wang, CR Simoneau, J Kulsuptrakul, M Bouhaddou, KA Travisano, ... Cell 184 (1), 106-119. e14, 2021 | 365 | 2021 |
| Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1 WF Garcia-Beltran, A Hölzemer, G Martrus, AW Chung, Y Pacheco, ... Nature immunology 17 (9), 1067-1074, 2016 | 237 | 2016 |
| Androgen signaling regulates SARS-CoV-2 receptor levels and is associated with severe COVID-19 symptoms in men RM Samuel, H Majd, MN Richter, Z Ghazizadeh, SM Zekavat, A Navickas, ... Cell Stem Cell 27 (6), 876-889. e12, 2020 | 233 | 2020 |
| SARS-CoV-2 infection of human iPSC–derived cardiac cells reflects cytopathic features in hearts of patients with COVID-19 JA Perez-Bermejo, S Kang, SJ Rockwood, CR Simoneau, DA Joy, ... Science translational medicine 13 (590), eabf7872, 2021 | 226* | 2021 |
| Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination RK Suryawanshi, IP Chen, T Ma, AM Syed, N Brazer, P Saldhi, ... Nature 607 (7918), 351-355, 2022 | 194 | 2022 |
| Tropism of SARS-CoV-2 for human cortical astrocytes MG Andrews, T Mukhtar, UC Eze, CR Simoneau, J Ross, N Parikshak, ... Proceedings of the National Academy of Sciences 119 (30), e2122236119, 2022 | 131* | 2022 |
| Inconsistent HIV reservoir dynamics and immune responses following anti-PD-1 therapy in cancer patients with HIV infection EP Scully, RL Rutishauser, CR Simoneau, H Delagrèverie, Z Euler, ... Annals of Oncology 29 (10), 2141-2142, 2018 | 61 | 2018 |
| HIV-1-mediated downmodulation of HLA-C impacts target cell recognition and antiviral activity of NK cells C Koerner, CR Simoneau, P Schommers, M Granoff, M Ziegler, ... Cell host & microbe 22 (1), 111-119. e4, 2017 | 43 | 2017 |
| Modeling multi-organ infection by SARS-CoV-2 using stem cell technology CR Simoneau, M Ott Cell stem cell 27 (6), 859-868, 2020 | 34 | 2020 |
| Modelling T-cell immunity against hepatitis C virus with liver organoids in a microfluidic coculture system V Natarajan, CR Simoneau, AL Erickson, NL Meyers, JL Baron, S Cooper, ... Open biology 12 (3), 210320, 2022 | 28 | 2022 |
| SARS-CoV-2 infection of airway organoids reveals conserved use of Tetraspanin-8 by Ancestral, Delta, and Omicron variants L Hysenaj, S Little, K Kulhanek, M Magnen, K Bahl, OM Gbenedio, ... Stem cell reports 18 (3), 636-653, 2023 | 21* | 2023 |
| Sensitive and multiplexed RNA detection with Cas13 droplets and kinetic barcoding S Son, A Lyden, J Shu, SI Stephens, P Fozouni, GJ Knott, DCJ Smock, ... MedRXiv, 2021.08. 02.21261509, 2021 | 12 | 2021 |
| Influence of Glycosylation Inhibition on the Binding of KIR3DL1 to HLA-B* 57: 01 W Salzberger, WF Garcia-Beltran, H Dugan, S Gubbala, C Simoneau, ... PLoS One 10 (12), e0145324, 2015 | 10 | 2015 |
| IL-10 driven memory T cell survival and Tfh differentiation promote HIV persistence SP Ribeiro, M Aid, FP Dupuy, CN Chan, J Hultquist, C Delage, E Moysi, ... BioRxiv, 2021.02. 26.432955, 2021 | 8 | 2021 |
| Immediate myeloid depot for SARS-CoV-2 in the human lung M Magnen, R You, AA Rao, RT Davis, L Rodriguez, CR Simoneau, ... Research Square, 2022 | 5 | 2022 |
| NK-cell activation is associated with increased HIV transcriptional activity following allogeneic hematopoietic cell transplantation LE Hogan, C Körner, K Hobbs, CR Simoneau, C Thanh, EA Gibson, ... Blood Advances 2 (12), 1412-1416, 2018 | 4 | 2018 |
| Assessment of the antiviral capacity of primary natural killer cells by optimized in vitro quantification of HIV-1 replication X He, CR Simoneau, ME Granoff, S Lunemann, AS Dugast, Y Shao, ... Journal of immunological methods 434, 53-60, 2016 | 4 | 2016 |
